Skip to main content
BIOF
OTC Industrial Applications And Services

Blue Biofuels Q3: Cash Down to $6,473, Going-Concern Warning Reiterated

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Negative
Importance info
8
Price
$0.115
Mkt Cap
$37.309M
52W Low
$0.066
52W High
$0.2
52W Position info
74% above low
Off High info
42% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BIOF sits 74% above its 52-week low of $0.066.

Summary

Blue Biofuels posted a Q3 net loss of $1.39 million with only $6,473 of cash left and repeated its going-concern warning, leaving the company dependent on insider loans and small private placements to fund operations.


Key Events · Earnings and Guidance · BIOF

  • Cash Nearly Exhausted

    Cash and equivalents fell to $6,473 at September 30, 2026 from $65,200 at December 31, 2025, against a working capital deficit of $3,659,437.

  • Going-Concern Warning Repeated

    Accumulated deficit reached $62,930,226, and management states substantial doubt about the company's ability to continue as a going concern absent new financing.

  • Q3 Loss Widened

    Net loss for the quarter was $1,385,268 versus $422,547 a year earlier; nine-month loss was $2,799,864 versus $1,587,132, with $805,834 of Q3 stock-based compensation.

  • Debt Rose on Insider Loans

    Total notes payable increased to $2,384,000 from $1,835,630, including $260,000 borrowed from director Chris Kneppers and $274,000 of convertible notes from unrelated parties.


Analysis · BIOF · Industrial Applications And Services

With cash of just $6,473 at September 30 against a $3.66 million working capital deficit and a $62.9 million accumulated deficit, management again flags substantial doubt about the company's ability to continue as a going concern. The quarter's $1.39 million net loss was more than triple the prior-year period, driven largely by non-cash stock compensation of $805,834. Survival now hinges entirely on continued related-party lending and small private placements: the company raised $347,000 of equity and $649,000 of notes in the first nine months, and after quarter-end took another $87,000 from a board member and $186,000 from an unrelated lender convertible at $0.09. The June 24 board action also committed to issuing anti-dilution options to four executives on every future raise through the next $50 million, so each new financing further dilutes outside holders.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BIOF was trading at $0.12 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $37.3M. The 52-week trading range was $0.07 to $0.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIOF - Latest Insights

BIOF
Aug 10, 2026, 6:05 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.108855
Real-time Price: $0.115 info
Change: +$0.006145 (+6%) info
Market Cap: $37.309M info
BIOF
Jun 08, 2026, 9:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.120
Real-time Price: $0.115 info
Change: -$0.0050 (-4%) info
Market Cap: $37.309M info
BIOF
May 04, 2026, 12:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.159
Real-time Price: $0.115 info
Change: -$0.044 (-28%) info
Market Cap: $37.309M info
BIOF
Mar 19, 2026, 11:17 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.16005
Real-time Price: $0.115 info
Change: -$0.04505 (-28%) info
Market Cap: $37.309M info